BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32735822)

  • 1. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal hematopoiesis: Molecular basis and clinical relevance.
    Kunimoto H; Nakajima H
    Leuk Res; 2020 Nov; 98():106457. PubMed ID: 33010619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
    Singh I; Singh A
    Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
    Haybar H; Shahrabi S; Ghanavat M; Khodadi E
    J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):279-291. PubMed ID: 32783925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.
    McClatchy J; Strogantsev R; Wolfe E; Lin HY; Mohammadhosseini M; Davis BA; Eden C; Goldman D; Fleming WH; Conley P; Wu G; Cimmino L; Mohammed H; Agarwal A
    Nat Commun; 2023 Dec; 14(1):8102. PubMed ID: 38062031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
    Huang YC; Wang CY
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
    Kumar P; Kopecky SL; Yang EH; Oren O
    Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis and vascular disease.
    Amancherla K; Wells JA; Bick AG
    Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
    Yu X; Qian N; Wang Y
    Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
    Saadatagah S; Ballantyne CM
    Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity-induced inflammation exacerbates clonal hematopoiesis.
    Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
    Menendez-Gonzalez JB; Rodrigues NP
    Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.